We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.69%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.2B
AUM Growth
+$1.14B
(+8.1%)
Cap. Flow
+$754M
Cap. Flow
% of AUM
4.96%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
1,269
New
352
Increased
317
Reduced
269
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$124M |
| 2 |
Texas Instruments
TXN
|
+$113M |
| 3 |
UnitedHealth
UNH
|
+$106M |
| 4 |
Philip Morris
PM
|
+$106M |
| 5 |
TJX Companies
TJX
|
+$93.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$240M |
| 2 |
Zoetis
ZTS
|
+$221M |
| 3 |
Constellation Brands
STZ
|
+$123M |
| 4 |
Moody's
MCO
|
+$112M |
| 5 |
Estee Lauder
EL
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.99% |
| 2 | Consumer Discretionary | 12.3% |
| 3 | Technology | 11.57% |
| 4 | Communication Services | 10.98% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Coherus Oncology
CHRS
$217M
| $1.02M | 0.01% |
+36,303
| New | +$1.02M |
|
|
LM
752
DELISTED
Legg Mason, Inc.
LM
| $1.02M | 0.01% |
34,012
-33,292
| -49% | -$1.05M |
|
753
Caesars Entertainment
CZR
$6.1B
| $1M | 0.01% |
+59,259
| New | +$830K |
|
|
FRGI
754
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1M | 0.01% |
+33,585
| New | +$934K |
|
755
Genuine Parts
GPC
$17.1B
| $983K | 0.01% |
10,285
+3,767
| +58% | +$359K |
|
|
MSCC
756
DELISTED
Microsemi Corp
MSCC
| $980K | 0.01% |
18,154
+5,143
| +40% | +$251K |
|
757
Core Laboratories
CLB
$538M
| $968K | 0.01% |
8,065
-62,437
| -89% | -$6.91M |
|
758
Old Republic International
ORI
$10.3B
| $959K | 0.01% |
+50,456
| New | +$908K |
|
759
Choice Hotels
CHH
$5.03B
| $956K | 0.01% |
17,055
-11,397
| -40% | -$571K |
|
760
Cummins
CMI
$91.7B
| $955K | 0.01% |
+6,985
| New | +$935K |
|
761
XPO
XPO
$25B
| $943K | 0.01% |
+63,157
| New | +$880K |
|
762
Avient
AVNT
$3.45B
| $942K | 0.01% |
+29,405
| New | +$945K |
|
763
Gildan
GIL
$9.25B
| $932K | 0.01% |
+36,726
| New | +$978K |
|
|
CLC
764
DELISTED
Clarcor
CLC
| $930K | 0.01% |
+11,282
| New | +$796K |
|
765
Adeia
ADEA
$2.86B
| $923K | 0.01% |
78,976
-1,528,235
| -95% | -$16.2M |
|
766
Resources Connection
RGP
$129M
| $908K | 0.01% |
+47,163
| New | +$755K |
|
767
Essex Property Trust
ESS
$18.9B
| $901K | 0.01% |
+3,874
| New | +$837K |
|
768
Starbucks
SBUX
$118B
| $897K | 0.01% |
16,150
-94,273
| -85% | -$5.22M |
|
|
INXN
769
DELISTED
Interxion Holding N.V.
INXN
| $891K | 0.01% |
25,412
-71,886
| -74% | -$2.56M |
|
770
Cenovus Energy
CVE
$54.6B
| $882K | 0.01% |
58,304
-143,628
| -71% | -$2.16M |
|
771
Mueller Water Products
MWA
$3.92B
| $879K | 0.01% |
+66,041
| New | +$847K |
|
772
PVH
PVH
$3.71B
| $874K | 0.01% |
9,685
-78,065
| -89% | -$8.21M |
|
|
HMHC
773
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $868K | 0.01% |
80,027
-120,881
| -60% | -$1.42M |
|
774
Alarm.com
ALRM
$2.56B
| $867K | 0.01% |
+31,163
| New | +$905K |
|
|
BPMC
775
DELISTED
Blueprint Medicines
BPMC
| $850K | 0.01% |
+30,302
| New | +$913K |
|
Similar funds
Marshall Wace's Q4 2016 Portfolio in Review
As of Q4 2016, Marshall Wace held 1,269 positions worth $15.2B, up 8.1% from $14.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $754M of net new capital in Q4 2016, opening 352 new positions and adding to 317 existing holdings. Its largest new stake was Texas Instruments: 1,581,130 shares worth $115M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Zoetis, an estimated $221M trimmed.
- Marshall Wace's largest Q4 2016 buy was Texas Instruments: 1,581,130 shares worth $115M.
- Marshall Wace added most to Amazon in Q4 2016, an estimated $124M increase.
- Marshall Wace's biggest Q4 2016 reduction was Zoetis, cutting an estimated $221M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q4 2016, selling an estimated $240M.
- Marshall Wace's ten largest holdings make up 16% of its $15.2B portfolio in Q4 2016.
- Marshall Wace opened 352 new positions and closed 320 in Q4 2016.
- Marshall Wace's portfolio value rose 8.1% quarter-over-quarter to $15.2B.
Based on Marshall Wace's 13F filing for Q4 2016, filed 10 Feb 2017.